The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway

Kallikrein-related peptidase 5 (KLK5) displays aberrant expression in cancer. However, any functional association is missing. Here, we show that reconstitution of KLK5 expression in non-expressing MDA-MB-231 breast cancer cells suppresses malignancy in vitro and in vivo dose-dependently. Reactivatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Pampalakis, Georgios, Obasuyi, Osahon, Papadodima, Olga, Chatziioannou, Aristotelis, Zoumpourlis, Vassileios, Sotiropoulou, Georgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058013/
https://www.ncbi.nlm.nih.gov/pubmed/24158494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058013/
https://www.ncbi.nlm.nih.gov/pubmed/24158494

Ejemplares similares